2/25
06:24 am
axsm
Axsome Therapeutics (AXSM) was upgraded by Wolfe Research to "strong-buy".
Medium
Report
Axsome Therapeutics (AXSM) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
axsm
Axsome Therapeutics (AXSM) was upgraded by Wolfe Research to "strong-buy".
Medium
Report
Axsome Therapeutics (AXSM) was upgraded by Wolfe Research to "strong-buy".
2/24
02:15 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
11:27 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
11:27 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
11:07 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
11:07 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
10:04 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/24
10:04 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/24
09:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
09:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
09:11 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
2/24
07:26 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/24
07:26 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/24
07:18 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
2/24
07:01 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/24
07:01 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/23
06:01 pm
axsm
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
06:01 pm
axsm
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
04:10 pm
axsm
Axsome Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Axsome Therapeutics initiated with an Outperform at Wolfe Research
2/23
04:10 pm
axsm
Axsome Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Axsome Therapeutics initiated with an Outperform at Wolfe Research
2/23
08:37 am
axsm
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $225.00 price target on the stock.
Low
Report
Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $225.00 price target on the stock.
2/23
08:17 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/23
08:17 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/3
07:34 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM